• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Edgewise

Edgewise Therapeutics

A Movement in Muscle

  • Clinical Trials
  • Careers
  • Investors & News
  • Company
    • Company Overview
    • Leadership Team
    • Careers
    • Contact Us

    Our vision is to improve the lives of patients and families suffering from serious muscle diseases by building the world’s leading muscle-focused company.

    Learn More

  • Science
    • Science Overview
    • Pipeline
    • Sevasemten
    • EDG-7500
    • EDG-15400
    • Clinical Trials
    • Posters & Presentations

    All of us at Edgewise are committed to developing new medicines for people facing serious muscle diseases with unmet medical needs.

    Explore our Science

  • Disease Areas
    • Disease Areas Overview
    • Muscular Dystrophy
    • Cardiovascular Diseases

    Learn more about how our science is driving a new understanding of muscle and its potential to transform human health.

    Explore Muscle

  • Patients & Families
    • Patients & Families Overview
    • Support for Becker
    • Support for Duchenne
    • Support for HCM
    • Patient Stories

    We honor the experience of individuals and families living with and facing the challenges of serious muscle disease.

    Read their Stories

  • Investors & News
    • Corporate Profile
    • News
    • Events & Presentations
    • Analyst Coverage
    • Stock Info
      • Stock Quote
      • Stock Chart
      • Historical Stock Quote
      • Investment Calculator
    • Financials
      • Quarterly Results
      • SEC Filings
    • Governance
      • Governance Documents
      • Committee Composition
    • Resources
      • Investor FAQs
      • Investor Email Alerts
      • Investor Contacts
HomeCompanyContact Us

Contact Us

Get a word in Edgewise

Whether you’re inquiring about a clinical trial, an open position, our clinical progress in serious muscle diseases, or need other information, we want to hear from you.

Complete and submit the form, and your request will be forwarded to the appropriate department.

Contact Information

Edgewise Headquarters
1715 38th St, Boulder, CO, 80301
(720) 262-7002
info@edgewisetx.com

Footer

Edgewise Therapeutics
  • Disease Areas
  • Science
  • Patients & Families
  • Company
  • Investors & News

In the Clinic

We are advancing novel precision therapeutics for serious muscle disease.

Explore our pipeline

2025 © Copyright. Edgewise Therapeutics. All Rights Reserved.

  • Privacy Policy
  • Terms of Use
Facebook X, formally Twitter LinkedIn Instagram YouTube
logo
  • Company
    • Leadership Team
    • Careers
    • Contact Us
  • Science
    • Pipeline
    • Sevasemten
    • EDG-7500
    • EDG-15400
    • Clinical Trials
    • Posters & Presentations
  • Disease Areas
    • Muscular Dystrophy
    • Cardiovascular Diseases
  • Patients & Families
    • Support for Becker
    • Support for Duchenne
    • Support for HCM
    • Patient Stories
  • Investors & Media
    • Corporate Profile
    • News
    • Events & Presentations
    • Analyst Coverage
    • Stock Info
      • Stock Quote
      • Stock Chart
      • Historical Stock Quote
      • Investment Calculator
    • Financials
      • Quarterly Results
      • SEC Filings
    • Goverance
      • Governance Documents
      • Committee Composition
    • Resources
      • Investor FAQs
      • Investor Email Alerts
      • Investor Contacts